Published in Respiration on January 27, 2006
Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis | NCT02913365
Bronchoscopy as a supplement to computed tomography in patients with haemoptysis may be unnecessary. Eur Clin Respir J (2016) 0.75
Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J (2011) 2.08
Protective effect of fruits, vegetables and the Mediterranean diet on asthma and allergies among children in Crete. Thorax (2007) 1.98
Prioritising the respiratory research needs of primary care: the International Primary Care Respiratory Group (IPCRG) e-Delphi exercise. Prim Care Respir J (2012) 1.77
The International Primary Care Respiratory Group (IPCRG) Research Needs Statement 2010. Prim Care Respir J (2010) 1.76
Sleep patterns in patients with acute coronary syndromes. Sleep Med (2010) 1.74
Is a miliary chest pattern always indicative of tuberculosis or malignancy? Respiration (2006) 1.67
Allergic rhinitis, asthma, and atopy among grape farmers in a rural population in Crete, Greece. Chest (2005) 1.56
Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med (2012) 1.52
Induced sputum versus bronchoalveolar lavage fluid in the evaluation of patients with idiopathic pulmonary fibrosis. Respiration (2005) 1.44
Smoking-related emphysema is associated with idiopathic pulmonary fibrosis and rheumatoid lung. Respirology (2013) 1.43
Vascular-specific growth factor mRNA levels in the human diaphragm. Respiration (2005) 1.42
Exhaled breath condensate 8-isoprostane, clinical parameters, radiological indices and airway inflammation in COPD. Respiration (2007) 1.42
Idiopathic pulmonary fibrosis: outcome in relation to smoking status. Am J Respir Crit Care Med (2007) 1.41
Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD. Chest (2004) 1.39
Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis. Chest (2005) 1.39
GOLD COPD categories are not fit for purpose in primary care. Lancet Respir Med (2013) 1.37
Apoptotic mechanisms in the pathogenesis of COPD. Int J Chron Obstruct Pulmon Dis (2006) 1.31
Primary deep sclerectomy versus primary deep sclerectomy with the use of mitomycin C in primary open-angle glaucoma. J Glaucoma (2002) 1.31
Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications. World J Gastroenterol (2005) 1.28
Atrial overdrive pacing for the obstructive sleep apnea-hypopnea syndrome. N Engl J Med (2005) 1.26
Dyspnea assessment and adverse events during sputum induction in COPD. BMC Pulm Med (2006) 1.15
Sleep disordered breathing in patients with acute coronary syndromes. J Clin Sleep Med (2012) 1.14
Preventing exacerbations of COPD--advice from Hippocrates. N Engl J Med (2011) 1.11
Isolation of myeloid and plasmacytoid dendritic cells from human bronchoalveolar lavage fluid. Immunol Cell Biol (2006) 1.10
UNLOCK: Uncovering and Noting Long-term Outcomes in COPD to enhance knowledge. Prim Care Respir J (2010) 1.07
Survivin -31G/C promoter polymorphism and sporadic colorectal cancer. Int J Colorectal Dis (2008) 1.07
Vascular endothelial growth factor and endoglin (CD-105) in gastric cancer. Gastric Cancer (2007) 1.03
Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis. Chest (2006) 1.02
Clinical presentation and management of empyema, lung abscess and pleural effusion. Curr Opin Pulm Med (2006) 0.98
Streptomyces pneumonia in an immunocompetent patient: a case report and literature review. Diagn Microbiol Infect Dis (2007) 0.97
Prognostic value of serum tumor markers in patients with lung cancer. Respiration (2002) 0.96
Induced sputum CD8+ T-lymphocyte subpopulations in chronic obstructive pulmonary disease. Respir Med (2004) 0.95
Is there any correlation between the ATS, BTS, ERS and GOLD COPD's severity scales and the frequency of hospital admissions? Respir Med (2004) 0.94
The relationships among hydrogen peroxide in expired breath condensate, airway inflammation, and asthma severity. Chest (2002) 0.94
Nitrosative stress, heme oxygenase-1 expression and airway inflammation during severe exacerbations of COPD. Chest (2005) 0.93
Decreased small airway and alveolar CD83+ dendritic cells in COPD. Chest (2009) 0.93
Expression of nuclear factor kappaB in human gastric carcinoma: relationship with I kappaB a and prognostic significance. Virchows Arch (2007) 0.93
Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis. Int J Oncol (2012) 0.93
Upregulation of Th1 cytokine profile (IL-12, IL-18) in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis. J Interferon Cytokine Res (2006) 0.92
Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis. Pulm Pharmacol Ther (2006) 0.92
Smoking and pulmonary fibrosis: novel insights. Pulm Med (2011) 0.92
Association of allergic rhinitis with pesticide use among grape farmers in Crete, Greece. Occup Environ Med (2006) 0.92
Severe airway stenosis associated with Crohn's disease: case report. BMC Pulm Med (2006) 0.92
Exhaled H(2)O(2) in steady-state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease. Chest (2002) 0.91
Deregulation of apoptosis mediators' p53 and bcl2 in lung tissue of COPD patients. Respir Res (2010) 0.91
Air travel for patients with chronic obstructive pulmonary disease: a case report. Br J Gen Pract (2012) 0.90
Changes in sputum T-lymphocyte subpopulations at the onset of severe exacerbations of chronic obstructive pulmonary disease. Respir Med (2004) 0.90
Interferon-gamma 1b for the treatment of idiopathic pulmonary fibrosis. Expert Opin Biol Ther (2006) 0.90
The role of macrophages in obstructive airways disease: chronic obstructive pulmonary disease and asthma. Cytokine (2013) 0.90
Asthma in the Elderly: Can We Distinguish It from COPD? J Allergy (Cairo) (2011) 0.90
Association of the miR-146aC>G, miR-149T>C, and miR-196a2T>C polymorphisms with gastric cancer risk and survival in the Greek population. Mol Biol Rep (2013) 0.90
Expression analysis of angiogenic growth factors and biological axis CXCL12/CXCR4 axis in idiopathic pulmonary fibrosis. Connect Tissue Res (2010) 0.90
Biomarkers in COPD. Curr Med Chem (2007) 0.89
Decreased sputum mature dendritic cells in healthy smokers and patients with chronic obstructive pulmonary disease. Int Arch Allergy Immunol (2009) 0.89
Long-term omalizumab treatment in severe allergic asthma: the South-Eastern Mediterranean "real-life" experience. Pulm Pharmacol Ther (2011) 0.89
Angiogenic molecule Tie-2 and VEGF in the pathogenesis of pleural effusions. Respir Med (2008) 0.88
Effect of Mediterranean diet versus prudent diet combined with physical activity on OSAS: a randomised trial. Eur Respir J (2011) 0.88
C-reactive protein evolution in obstructive sleep apnoea patients under CPAP therapy. Eur J Clin Invest (2010) 0.88
Investigation of bone marrow mesenchymal stem cells (BM MSCs) involvement in Idiopathic Pulmonary Fibrosis (IPF). Respir Med (2010) 0.88
Different activity of the biological axis VEGF-Flt-1 (fms-like tyrosine kinase 1) and CXC chemokines between pulmonary sarcoidosis and idiopathic pulmonary fibrosis: a bronchoalveolar lavage study. Clin Dev Immunol (2010) 0.88
Expression analysis of Akt and MAPK signaling pathways in lung tissue of patients with idiopathic pulmonary fibrosis (IPF). J Recept Signal Transduct Res (2010) 0.87
Altered surfactant protein-A expression in type II pneumocytes in COPD. Chest (2009) 0.87
The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic ductal and ampullary carcinoma and their relation to angiogenesis and clinicopathological parameters. Anticancer Res (2008) 0.87
Different angiogenic CXC chemokine levels in bronchoalveolar lavage fluid after interferon gamma-1b therapy in idiopathic pulmonary fibrosis patients. Pulm Pharmacol Ther (2008) 0.87
Effects of antifibrotic agents on TGF-beta1, CTGF and IFN-gamma expression in patients with idiopathic pulmonary fibrosis. Respir Med (2007) 0.86
Bronchial artery embolization for management of massive cryptogenic hemoptysis: a case series. J Med Case Rep (2011) 0.86
Dietary meat fats and burden of cardiovascular disease risk factors, in the elderly: a report from the MEDIS study. Lipids Health Dis (2010) 0.86
Oxidative DNA damage and somatic mutations: a link to the molecular pathogenesis of chronic inflammatory airway diseases. Chest (2011) 0.86
Managing comorbidity in COPD: a difficult task. Curr Drug Targets (2013) 0.85
Detection of herpes simplex virus type-1 in patients with fibrotic lung diseases. PLoS One (2011) 0.85
Morphometric microvascular characteristics in the prognosis of pancreatic and ampullary carcinoma. Pancreas (2007) 0.85
Pulmonary involvement and allergic disorders in inflammatory bowel disease. World J Gastroenterol (2010) 0.84
Sputum and nasal lavage lung-specific biomarkers before and after smoking cessation. BMC Pulm Med (2011) 0.84